MITIHEART®

In order to capitalize on the market potential of the MiTi Heart® blood pump, Mohawk Innovative Technology, Inc. (MiTi®) made a strategic decision to spin off the blood pump technology and establish the MiTi Heart® Corporation, a wholly-owned subsidiary. MiTi Heart® Corporation was established as a Delaware ‘C' corporation on February 5, 2003 to develop and market unique blood pumps for patients suffering from congestive heart failure. $15 Million in technology investment established the efficacy of the prototype MiTi Heart® blood pump and has significantly reduced the technical risks. With patent protection of the novel idea behind the MiTi Heart® LVAD, and collaborations developed with the Hershey Medical Center and other leading organizations, MiTi Heart® Corporation is ready to move into the next phase and prepare the MiTi Heart® LVAD for approval by the Food and Drug Administration (FDA). The original MiTi blood pump patents and the MiTi Heart® trademarks have been exclusively..

Also known as: MiTiHeart® Corporation

Primary location: Albany United States